美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA207165"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
64980-566-01 64980-566 HUMAN PRESCRIPTION DRUG Dapsone dapsone TABLET ORAL 20221211 N/A ANDA ANDA207165 Rising Pharma Holdings, Inc. DAPSONE 100 mg/1 100 TABLET in 1 BOTTLE (64980-566-01)
64980-566-03 64980-566 HUMAN PRESCRIPTION DRUG Dapsone dapsone TABLET ORAL 20230712 N/A ANDA ANDA207165 Rising Pharma Holdings, Inc. DAPSONE 100 mg/1 30 TABLET in 1 BOTTLE (64980-566-03)
64980-567-01 64980-567 HUMAN PRESCRIPTION DRUG Dapsone dapsone TABLET ORAL 20230720 N/A ANDA ANDA207165 Rising Pharma Holdings, Inc. DAPSONE 25 mg/1 100 TABLET in 1 BOTTLE (64980-567-01)
64980-567-03 64980-567 HUMAN PRESCRIPTION DRUG Dapsone dapsone TABLET ORAL 20230829 N/A ANDA ANDA207165 Rising Pharma Holdings, Inc. DAPSONE 25 mg/1 30 TABLET in 1 BOTTLE (64980-567-03)
67046-1477-3 67046-1477 HUMAN PRESCRIPTION DRUG Dapsone dapsone TABLET ORAL 20250131 N/A ANDA ANDA207165 Coupler LLC DAPSONE 100 mg/1 30 TABLET in 1 BLISTER PACK (67046-1477-3)
83209-566-30 83209-566 HUMAN PRESCRIPTION DRUG Dapsone dapsone TABLET ORAL 20240830 N/A ANDA ANDA207165 Boswell Pharmacy Services LLC d/b/a BPS Wholesale DAPSONE 100 mg/1 30 TABLET in 1 BLISTER PACK (83209-566-30)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2025 Drugfuture->U.S. FDA National Drug Code DataBase